Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL 4:00:00 PM EDT

9.16

+0.64 (+7.51%)

4:41:51 PM EDT: $8.98 -0.18 (-1.97%)

Products

Avadel Pharmaceuticals Announces Submission Of New Drug Application For FT218 To FDA

Published: 12/16/2020 14:05 GMT

Avadel Pharmaceuticals plc - ADR (AVDL) - Avadel Pharmaceuticals Announces Submission of New Drug Application for Ft218 to the FDA.